Objectives: The objective of this study was to determine the biological cost, stability and sequence of two carbapenemase-encoding plasmids containing bla KPC-2 (pG12-KPC-2) and bla VIM-1 (pG06-VIM-1) isolated from Klebsiella pneumoniae when newly acquired by uropathogenic Escherichia coli clinical isolates of different genetic backgrounds.
Introduction
Plasmids can carry multiple resistance genes that can disseminate multidrug resistance (MDR) through horizontal gene transfer in and between bacterial populations. 1 The emergence and acquisition of plasmid-mediated carbapenemases in Gram-negatives represent a serious clinical challenge. 2 Carbapenemases have broad-spectrum activity making virtually all clinically relevant b-lactams ineffective, resulting in frequent treatment failures. 2 Dissemination of acquired carbapenemases is enhanced by their presence on plasmids with different genetic backbones and association with other mobile genetic elements (MGEs), creating a potential for further spread of these enzymes to other Enterobacteriaceae. Following successful transfer events, the stability and persistence of newly acquired plasmids largely depend on the fitness cost imposed on new hosts in the absence of selective pressure on traits harboured by the plasmid. 3, 4 Thus, understanding transmission dynamics of plasmids between species and interactions between plasmids and host genetic backgrounds might contribute to minimize the dissemination of these MDR plasmids. Here, we investigated the fitness effect, stability and sequence of two carbapenemase-encoding plasmids, pG12-KPC-2 and pG06-VIM-1, isolated from Klebsiella pneumoniae when newly acquired by uropathogenic Escherichia coli of different genetic backgrounds.
Materials and methods

Bacterial isolates, transformants and susceptibility testing
Bacterial strains used in this study and their relevant characteristics are given in Table S1 (available as Supplementary data at JAC Online). Strains were grown under aeration at 378C in LB and/or Super Optimal Broth (SOB) agar or broth. Plasmids were transferred into E. coli of various genetic backgrounds by electroporation and transformants selected on lactose agar with 100 mg/L ampicillin. Transformants were screened by PCR for bla VIM 5 or bla KPC 6 genes and further analysed using S1 nuclease PFGE followed by hybridization with bla VIM and bla KPC probes 7 (data not shown). Susceptibility profiles were determined by Etest (bioMérieux, France).
Plasmid stability, fitness measurements and statistical analysis
Transformants were propagated by serial transfer 4 for 312 generations and plated on non-selective LB agar. One hundred colonies were patched on LB agar with 100 mg/L ampicillin. Plasmid presence was checked by colony PCR targeting bla VIM 5 or bla KPC 6 and repB or repA. 8, 9 Relative fitness of the newly acquired plasmids was determined in 24 h head-to-head competitions with their plasmid-free isogenic ancestors 4 in both LB and minimal (M9 with 0.2% glucose) media. Initial and final titres of each competitor were determined by selective (100 mg/L ampicillin) and nonselective plating and the relative fitness calculated. 10 Fitness data were assessed using a two-way ANOVA with Tukey's honest significant difference (HSD) correction between the different transformants. Fitness cost of plasmid carriage compared with the plasmid-free ancestor was assessed with one-sample t-tests. Statistical analysis was performed in R (https://www.r-project.org/).
Generation of rifampicin-resistant mutants and filter mating
Spontaneous rifampicin-resistant mutants were obtained by spreading 100 mL of overnight cultures onto LB agar with 100 mg/L rifampicin. Transferability of the plasmids from the transformants to the corresponding rifampicin-resistant plasmid-free recipients was tested by filter mating. Transconjugants were selected on LB agar containing 100 mg/L rifampicin and 100 mg/L ampicillin.
DNA extraction and plasmid sequencing
Genomic DNA was isolated using anion exchange columns (Qiagen, Germany). Plasmid DNA from donor strains was isolated using the NucleoBond Xtra Midi/Maxi kit (Macherey-Nagel, Germany) following the manufacturer's instructions with proteinase K added during the lysis step and an extended incubation of 40 min.
Generation of long paired-end libraries and multiplexed sequencing using Roche/454 GS FLX Titanium technology were performed by Eurofins MWG Operon (Germany). Reads were de novo assembled using Newbler (454 Life Sciences, USA) and contigs were ordered relative to reference sequences using progressiveMauve (http://darlinglab.org/mauve/mauve. html). Assembly gaps were closed by Sanger sequencing (Applied Asterisks denote a significant relative fitness difference of pG12-KPC-2 carriage between G1-13 and G1-14 (P, 0.001) as well as between G1-14 and G1-17 (same strain, different plasmids, P ¼ 0.01). All the other transformants did not display different costs of carriage as identified by multiple comparisons with Tukey's HSD correction with relative fitness as the response variable and strain (four levels), plasmid (two levels) and growth medium (two levels) as explanatory variables.
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Biosystems, USA). Coding sequences were identified and annotated using RAST (http://rast.nmpdr.org), BLAST and Artemis. Sequence comparisons were carried out using Easyfig 2.1 (https://mjsull.github.io/Easyfig/). Plasmid sequences are deposited in GenBank under accession numbers KU665641 and KU665642.
Results and discussion
Characterization of transformants
We transferred plasmids pG12-KPC-2 and pG06-VIM-1 from two carbapenemase-producing K. pneumoniae clinical donor strains into plasmid-naive uropathogenic E. coli recipient strains of various genetic backgrounds by electroporation. pG12-KPC-2 was successfully transformed into two different genetic backgrounds (ST10 and ST69). pG06-VIM-1 was transformed into three different genetic backgrounds (ST537, ST95 and ST69). The recipient strain E. coli K56-75 (ST69) was successfully transformed with pG12-KPC-2 or pG06-VIM-1 (Table S1 ). The activity profile against b-lactams for the transformants was consistent with the expected activity profiles of KPC-2 and VIM-1 (Table S2) . No plasmid transfer was detected in filter mating assays between transformants and corresponding rifampicin-resistant plasmidfree mutants.
Plasmid stability
We also propagated the plasmid-containing E. coli in monocultures for 312 generations in the absence of antibiotics. Both plasmids were stably maintained in their respective backgrounds except in the ST69 background (Figure 1a) . No plasmid loss was observed during the time course of the 24 h competition experiments.
Biological costs of plasmid carriage
The relative fitness of plasmid carriage was estimated in mixed culture competitions with the corresponding plasmid-free isogenic ancestors in LB and M9 media. Costs of plasmid carriage were independent of LB and M9 media (P ¼ 0.42) and data were pooled in the analysis. Both plasmids reduced fitness in their new hosts ranging from 1.1% to 3.6% (all P values ,0.001) (Figure 1b) . A host-dependent difference was observed between strains G1-13 (phylogroup A, ST10) and G1-14 (phylogroup D, ST69) (P, 0.001) carrying pG12-KPC-2 ( Figure 1b) . This is consistent with recent reports demonstrating that fitness costs of newly acquired MGEs depend on the genetic background and/or environmental factors. 4, 11 When in the same genetic background (phylogroup D, ST69), pG12-KPC-2 and pG06-VIM-1 reduced fitness Biological cost of carbapenemase plasmids in E. coli JAC by 3.6% (G1-14-pG12-KPC-2) and 1.8% (G1-17-pG06-VIM-1), respectively (P¼ 0.01), revealing a plasmid-dependent difference.
No difference in relative fitness was observed between strains G1-15 (phylogroup B2, ST537), G1-16 (phylogroup B2, ST95) and G1-17 (phylogroup D, ST69) harbouring pG06-VIM-1 (all P values .0.27). pG12-KPC-2 and pG06-VIM-1 imposed low to modest reductions in fitness in E. coli of different genetic backgrounds including strains from phylogroups A and B2, frequently associated with human and animal commensal strains. 12 These results are worrying since commensal E. coli and K. pneumoniae coinhabit the gastrointestinal tract, a hotspot for horizontal gene transfer. 13 Even though our in vitro plasmid transfers to clinical E. coli were unsuccessful, conjugative transfer of pG12-KPC-2 to a laboratory E. coli has previously been shown.
14 Further, pG12-KPC-2 was responsible for a long-term plasmid outbreak where both interand intraspecies transfer were observed.
14 Transfer of other carbapenemase-encoding plasmids between K. pneumoniae and E. coli as well as other Enterobacteriaceae has been shown to occur in vivo. 15 Thus, the transformants characterized here provide important insight into carbapenemase-encoding plasmids and their interactions with E. coli hosts when newly acquired.
Sequence analysis of pG12-KPC-2 and pG06-VIM-1 pG12-KPC-2 was recovered from a KPC-producing K. pneumoniae strain, isolated from a hospital outbreak in southern Norway in 2007 -10. 14 It is 111 926 bp in length and belongs to both IncFI and IncFII groups ( Figure S1a ). It encodes antirestriction proteins ArdA and ArdB, stability proteins StbA and StbB, a copy of the single strand binding protein Ssb and the parAB partitioning operon. The transfer region comprises 37 genes and makes up 30% of the plasmid. The backbone sequence is 99% identical to the KPC-2-encoding pKpQIL-10 (accession number KJ146687) 16 and highly similar to KPC-3-encoding pKpQIL-like plasmids identified in the K. pneumoniae epidemic ST258 clone 17, 18 and to pKPN4 carrying bla SHV-12 (accession number CP000649). The bla KPC-2 region revealed the structure of the Tn4401a transposon (Figure 2a) , including a resolvase and a transposase, and ISKpn6 and ISKpn7. The association between bla KPC-2 and Tn4401 is worrisome due to the potential evolution of structural variations caused by recombination/transposition events and further mobilization of carbapenem resistance in Enterobacteriaceae. pG12-KPC-2 also harbours a disrupted bla OXA-9 as part of Tn501.
pG06-VIM-1 was isolated from a K. pneumoniae collected in 2006 in Sweden from a patient who had undergone medical treatment in Greece. 19 The plasmid is a 53 618 bp circular molecule and belongs to the IncR group ( Figure S1b ). pG06-VIM-1 exhibits 99% nucleotide identity to bla VIM-1 -encoding pKP1780 (accession number JX424614). The IncR fragment encodes a set of genes controlling RepB expression and plasmid copy number, the parAB operon, a VagCD toxin -antitoxin system, a plasmid stabilization system specified by ResD and a umuDC operon. No conjugative transfer region was identified, explaining its inability to be transferred through conjugation. In pG06-VIM-1, bla VIM-1 is part of a mosaic structure similar to that of the VIM-1-encoding pTC2 (accession number JQ824049) 20 (Figure 2b ). We hypothesize that this MDR region resulted from multiple genetic rearrangements that have led to the mosaic structure of pG06-VIM-1 and to its plasticity. pG06-VIM-1 also harbours a macrolide inactivation cluster [mphR, mrx and mph(A)] and a composite transposon (Tn4352) containing the aminoglycoside resistance gene aphA1.
Conclusions
In conclusion, we show that the fitness cost of plasmid carriage depends on the individual plasmid-host combinations. In addition, the combination of stable VIM-and KPC-plasmid maintenance in the absence of antibiotic selective pressures is worrying since it may indicate the potential for further dissemination and establishment in E. coli and other Enterobacteriaceae.
